New-News

Latest News

News

News

A recent published study by Professor Robert Bucki and colleagues has shown that CSA-131 has broad spectrum antifungal activity and

Colistin is the last agent used to combat bacteria that are resistant to the strongest antibiotics. Colistin has remained the

A recent published study by Professor Jordi Vila and his colleagues at the University of Barcelona, Spain has found that

N8 Medical News

Here you will find the latest information, including: press releases, events and presentations and blog posts.

Newsletter Sign-up

Interested in hearing whats new with N8 Medical? Sign-up to join our newsletter.

Contact us

Lets Get in Touch!

Follow now

mynewform

Basic contact form

N8 Medical, Inc. (N8 Medical) is a clinical-stage medical device company focused on commercializing medical devices that incorporate a novel class of active compounds called ceragenins.The subsidiaries for N8 Medical Inc are N8 Medical, LLC for Medical Device Development and Kinnear Pharmaceuticals, LLC for drug development.